Devyser wins tender in Italy worth approximately SEK 5.7 million – doubling test volumes compared with previous agreement
Devyser Diagnostics AB, through its Italian subsidiary, has been awarded a renewed tender by...
Devyser extends its transplant test to heart and lung patients
Devyser announced that One Lambda™ Devyser Accept cfDNA, its test for monitoring kidney transplant...
Relapse after allogeneic stem cell transplantation: Is it time for routine HLA loss testing?
Allogeneic hematopoietic stem cell transplantation (allo-HCT) remains one of the few potentially...
Same disease, different testing approaches: global survey highlights the need for standardized FH genetic testing
Familial hypercholesterolemia (FH) is a common inherited disorder affecting approximately 1 in 250...